Viewing Study NCT02179567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-03-02 @ 4:05 AM
Study NCT ID: NCT02179567
Status: TERMINATED
Last Update Posted: 2015-09-28
First Post: 2014-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC
Sponsor: Hellenic Oncology Research Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic NSCLC View
None Elderly View
None 1st Line View
None Bevacizumab-based treatment View